Bicara Therapeutics, Inc. (BCAX)
16.19
-0.64
(-3.80%)
USD |
NASDAQ |
Jan 02, 13:29
Bicara Therapeutics EPS Diluted (Quarterly): -0.6658 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Pfizer Inc. | 0.6197 |
| Oncotelic Therapeutics, Inc. | -0.0025 |
| Dogwood Therapeutics, Inc. | -8.203 |
| CEL-SCI Corp. | -0.7611 |
| AIM ImmunoTech, Inc. | -1.569 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -36.33M |
| Total Expenses (Quarterly) | 36.33M |
| Enterprise Value | 633.79M |
| Earnings Yield | -13.77% |
| Normalized Earnings Yield | -13.77 |